Canopy Growth (CGC) 8-K Results of Operations and Financial Condition

Exhibit 99.5

NOTICE TO READER

As of September 30, 2019, Canopy Growth Corporation (the “Company”) determined that it no longer qualified as a “foreign private issuer” as such term is defined in Rule 405 under the Securities Act of 1933. This means that as of April 1, 2020, the Company has been required to comply with all of the periodic disclosure requirements of the Securities Exchange Act of 1934 applicable to U.S. domestic issues, such as Forms 10-K, 10-Q and 8-K, rather than the forms the Company has filed with the Securities and Exchange Commission (“SEC”) in the past as a foreign private issuer, such as Forms 40-F and 6-K.

Accordingly, the Company is now required to prepare its financial statements filed with the SEC in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). As required pursuant to section 4.3(4) of National Instrument 51-102 – Continuous Disclosure Obligations, the Company must restate its interim financial reports for the fiscal year ended March 31, 2020 in accordance with U.S. GAAP, such interim financial reports having previously been prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board.

The attached amended and restated condensed interim consolidated financial statements (“Financial Statements”) for the three and six months ended September 30, 2019 and 2018 have been prepared in accordance with U.S. GAAP, are current as of November 14, 2019 and provide financial information for the three and six months ended September 30, 2019, as amended and restated on July 10, 2020. Other than as expressly set forth above, the revised Financial Statements do not, and do not purport to, update or restate the information in the original condensed interim consolidated financial statements or reflect any events that occurred after the date of the filing of the original condensed interim consolidated financial statements.

The Company’s Annual Report on Form 10-K (the “Annual Report”) dated June 1, 2020 is available under the Company’s profile on SEDAR at www.sedar.com and on EDGAR at www.sec.gov. Readers are cautioned that these Financial Statements should be read in conjunction with the Annual Report, including the consolidated financial statements and the related notes thereto included in Item 8 thereof.

CANOPY GROWTH CORPORATION

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(IN CANADIAN DOLLARS)

CANOPY GROWTH CORPORATION

TABLE OF CONTENTS

Condensed interim consolidated balance sheets	1
Condensed interim consolidated statements of operations and comprehensive income (loss)	2
Condensed interim consolidated statements of changes in shareholders’ equity	3
Condensed interim consolidated statements of cash flows	4
Notes to the condensed interim consolidated financial statements	5-30

CANOPY GROWTH CORPORATION

CONDENSED INTERIM CONSOLIDATED BALANCE SHEETS

UNAUDITED

			September 30,			March 31,
(Expressed in CDN $000’s)	Notes		2019			2019
Assets
Current assets
Cash and cash equivalents		3	$	1,102,464		$	2,480,830
Short-term investments		4		1,633,692			2,034,133
Restricted short-term investments				18,252			21,432
Amounts receivable, net		5		107,487			106,974
Inventory		6		346,513			190,072
Prepaid expenses and other assets		7		118,111			85,691
				3,326,519			4,919,132
Equity method investments		8		113,046			112,385
Other financial assets		9		449,028			363,427
Property, plant and equipment		10		1,638,463			1,096,340
Intangible assets		11		554,455			558,070
Goodwill		12		1,858,288			1,489,859
Other assets				34,781			25,902
			$	7,974,580		$	8,565,115
Liabilities and Shareholders’ equity
Current liabilities
Accounts payable			$	249,596		$	188,920
Other accrued expenses and liabilities		13		37,266			37,613
Current portion of long-term debt		14		14,115			103,716
Other liabilities		15		142,816			81,414
				443,793			411,663
Long-term debt		14		590,373			842,259
Deferred income tax liabilities		24		101,984			105,081
Warrant derivative liability		26		450,894			—
Other liabilities		15		182,953			134,004
				1,769,997			1,493,007
Redeemable noncontrolling interest		16		9,300			6,400
Canopy Growth Corporation shareholders’ equity:
Common shares - $nil par value; Authorized - unlimited number of shares; Issued - 348,327,845 shares and 337,510,408 shares, respectively		17		6,333,929			6,029,222
Additional paid-in capital				2,548,882			1,592,024
Accumulated other comprehensive income (loss)		19		(21,362	)		(5,905	)
Deficit				(2,928,861	)		(835,118	)
Total Canopy Growth Corporation shareholder’s equity				5,932,588			6,780,223
Non-controlling interests		20		262,695			285,485
Total shareholders’ equity				6,195,283			7,065,708
Total liabilities and shareholders’ equity			$	7,974,580		$	8,565,115

The accompanying notes are an integral part of these condensed interim consolidated financial statements.

Page 1

CANOPY GROWTH CORPORATION

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME    

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018    

UNAUDITED

			Three months ended						Six months ended
			September 30,			September 30,			September 30,			September 30,
(Expressed in CDN $000’s except share amounts)	Notes		2019			2018			2019			2018
Revenue		22	$	85,621		$	23,327		$	189,012		$	49,243
Excise taxes		22		9,008			—			21,917			—
Net revenue		22		76,613			23,327			167,095			49,243
Cost of goods sold				72,970			42,663			145,162			61,115
Gross margin				3,643			(19,336	)		21,933			(11,872	)
Selling, general and administrative expenses				181,601			86,024			327,248			129,975
Share-based compensation				92,881			86,555			180,243			112,122
Total operating expenses				274,482			172,579			507,491			242,097
Operating loss				(270,839	)		(191,915	)		(485,558	)		(253,969	)
Loss from equity method investments		8		(2,171	)		(4,363	)		(4,004	)		(6,932	)
Other income (expense), net		23		509,893			(113,147	)		542,661			(144,316	)
Income (loss) before income taxes				236,883			(309,425	)		53,099			(405,217	)
Income tax recovery (expense)		24		5,767			(1,003	)		(4,500	)		1,490
Net income (loss)			$	242,650		$	(310,428	)	$	48,599		$	(403,727	)
Net (loss) income attributable to noncontrolling interests and redeemable noncontrolling interest				(16,268	)		7,402			(24,450	)		3,774
Net income (loss) attributable to Canopy Growth Corporation			$	258,918		$	(317,830	)	$	73,049		$	(407,501	)
						��
Basic income (loss) per share			$	0.75		$	(1.43	)	$	0.21		$	(1.93	)
Basic weighted average common shares outstanding				347,226,921			221,725,511			346,028,903			210,972,889
Diluted income (loss) per share			$	0.25		$	(1.43	)	$	0.19		$	(1.93	)
Diluted weighted average common shares outstanding				380,323,118			221,725,511			382,765,533			210,972,889
Comprehensive income (loss):
Net income (loss)				242,650			(310,428	)		48,599			(403,727	)
Fair value changes of own credit risk of financial liabilities				22,050			(65,610	)		36,660			(75,030	)
Foreign currency translation				8,627			(3,386	)		(52,117	)		(4,706	)
Total other comprehensive income (loss), net of income tax effect				30,677			(68,996	)		(15,457	)		(79,736	)
Comprehensive income (loss)				273,327			(379,424	)		33,142			(483,463	)
Comprehensive loss attributable to noncontrolling interests and redeemable noncontrolling interest				(16,268	)		7,402			(24,450	)		3,774
Comprehensive income (loss) attributable to Canopy Growth Corporation				289,595			(386,826	)		57,592			(487,237	)

The accompanying notes are an integral part of these condensed interim consolidated financial statements.    

Page 2

CANOPY GROWTH CORPORATION

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY    

FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018    

UNAUDITED

						Additional paid-in capital
(Expressed in CDN $000’s except share amounts)	Note			Common shares		Share- based reserve			Warrants			Ownership changes			Redeemable noncontrolling interest			Accumulated other comprehensive income (loss)			Deficit			Noncontrolling interests			Total
Balance at March 31, 2018				$	1,079,442	$	57,982		$	70,455		$	(1,019	)	$	(64,745	)	$	35,408		$	(132,904	)	$	85,732		$	1,130,351
Cumulative effect from adoption of ASU 2016-1					—		—			—			—			—			(34,800	)		34,800			—			—
Other issuances of common shares and warrants					966,708		226,674			—			(424,113	)		—			—			—			331			769,600
Exercise of warrants					322		—			(189	)		—			—			—			—			—			133
Exercise of Omnibus Plan stock options					51,669		(26,776	)		—			—			—			—			—			—			24,893
Share-based compensation					—		99,102			—			—			—			—			—			—			99,102
Issuance of replacement equity instruments					—		22,686			30,611			—			—			—			—			—			53,297
Issuance and vesting of restricted share units					2,191		56			—			—			—			—			—			—			2,247
Changes in redeemable noncontrolling interest					—		—			—			—			(20,760	)		—			—			1,810			(18,950	)
Ownership changes relating to noncontrolling interests					—		—			—			9,398			—			—			(769	)		119,661			128,290
Comprehensive income (loss)					—		—			—			—			—			(79,736	)		(407,501	)		3,774			(483,463	)
Balance at September 30, 2018				$	2,100,332	$	379,724		$	100,877		$	(415,734	)	$	(85,505	)	$	(79,128	)	$	(506,374	)	$	211,308		$	1,705,500
Balance at March 31, 2019				$	6,029,222	$	505,172		$	1,589,925		$	(500,963	)	$	(2,110	)	$	(5,905	)	$	(835,118	)	$	285,485		$	7,065,708
Other issuances of common shares and warrants		17			244,622		(244,877	)		359			—			—			—			—			—			104
Exercise of warrants		17	(iii)		932		—			(486	)		—			—			—			—			—			446
Exercise of Omnibus Plan stock options		18			58,764		(22,741	)		—			—			—			—			—			—			36,023
Share-based compensation		18			—		175,395			—			—			—			—			—			—			175,395
Issuance and vesting of restricted share units					389		(389	)		—			—			—			—			—			—			—
Acreage warrant modification		26			—		—			1,049,153			—			—			—			(2,166,792	)		—			(1,117,639	)
Changes in redeemable noncontrolling interest		19			—		—			—			—			779			—			—			(3,679	)		(2,900	)
Ownership changes relating to noncontrolling interests		20			—		—			—			(335	)		—			—			—			5,339			5,004
Comprehensive income (loss)					—		—			—			—			—			(15,457	)		73,049			(24,450	)		33,142
Balance at September 30, 2019				$	6,333,929	$	412,560		$	2,638,951		$	(501,298	)	$	(1,331	)	$	(21,362	)	$	(2,928,861	)	$	262,695		$	6,195,283

The accompanying notes are an integral part of these condensed interim consolidated financial statements.    

Page 3

CANOPY GROWTH CORPORATION

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS    

FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018    

UNAUDITED

			September 30,			September 30,
(Expressed in CDN $000’s)	Notes		2019			2018
Cash flows from operating activities
Net income (loss)			$	48,599		$	(403,727	)
Adjustments for:
Depreciation of property, plant and equipment				29,813			10,446
Amortization of intangible assets				15,955			5,236
Share of loss on equity investments		8		4,004			6,932
Share-based compensation		18		180,243			116,796
Income tax expense (recovery)		24		4,500			(1,490	)
Non-cash foreign currency				(1,463	)		(410	)
Interest paid				(12,750	)		—
Change in operating assets and liabilities, net of effects from purchases of businesses:
Amounts receivable				11,390			(21,242	)
Prepaid expenses and other assets				(50,224	)		(6,811	)
Inventory				(143,229	)		(28,964	)
Accounts payable and accrued liabilities				10,584			1,150
Other, including non-cash fair value adjustments				(469,507	)		123,948
Net cash used in operating activities				(372,085	)		(198,136	)
Cash flows from investing activities
Purchases of and deposits on property, plant and equipment				(440,150	)		(293,179	)
Purchases of intangible assets				(9,538	)		(6,341	)
Redemption (purchase) of short-term investments				388,027			(2,829	)
Investments in equity method investees		8		(4,719	)		(42,439	)
Investments in other financial assets		9		(36,423	)		(29,695	)
Investment in Acreage Arrangement		9, 26		(395,190	)		—
Change in acquisition related liabilities				(21,447	)		—
Net cash outflow on acquisition of NCI				—			(1,999	)
Net cash outflow on acquisition of subsidiaries		25		(416,028	)		428
Net cash used in investing activities				(935,468	)		(376,054	)
Cash flows from financing activities:
Payment of share issue costs				(129	)		(6,819	)
Proceeds from issuance of shares by Canopy Rivers				156			91,218
Proceeds from exercise of stock options		18		36,023			13,626
Proceeds from exercise of warrants		17		446			133
Issuance of long-term debt		14		5,278			600,000
Payment of debt issue costs		14		—			(16,380	)
Repayment of long-term debt				(104,282	)		(747	)
Net cash (used) provided by financing activities				(62,508	)		681,031
Effect of exchange rate changes on cash and cash equivalents				(8,305	)		—
Net cash (outflow) inflow				(1,378,366	)		106,841
Cash and cash equivalents, beginning of period				2,480,830			322,560
Cash and cash equivalents, end of period			$	1,102,464		$	429,401
Supplemental disclosure of cash flow information
Cash paid during the year:
Income taxes				1,305			—
Noncash investing and financing activities
Additions to property, plant and equipment				128,440			110,608

The accompanying notes are an integral part of these condensed interim consolidated financial statements.    

Page 4

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

1. DESCRIPTION OF BUSINESS

Canopy Growth Corporation is a publicly traded corporation, incorporated in Canada, with its head office located at 1 Hershey Drive, Smiths Falls, Ontario with its common shares listed on the TSX, under the trading symbol “WEED” and as of May 24, 2018 on the NYSE, under the trading symbol “CGC”. References in these condensed interim consolidated financial statements to “Canopy Growth” or “the Company” refer to Canopy Growth Corporation and its subsidiaries.

The principal activities of the Company are the production, distribution and sale of cannabis as regulated by the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) in Canada, up to and including October 16, 2018. On October 17, 2018, the ACMPR was superseded by The Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company is also expanding to jurisdictions outside of Canada where federally lawful and regulated for cannabis and/or hemp including subsidiaries which operate in the United States, Europe, Latin America and the Caribbean, Asia / Pacific, and Africa. Through its partially owned subsidiary Canopy Rivers Inc. (“Canopy Rivers”), the Company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector, where federally lawful.

2. BASIS OF PRESENTATION

These condensed interim consolidated financial statements have been presented in Canadian dollars and are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Canopy Growth has determined that the Canadian dollar is the most relevant and appropriate reporting currency as, despite continuing shifts in the relative size of our operations across multiple geographies, the majority of our operations are conducted in Canadian dollars and our financial results are prepared and reviewed internally by management in Canadian dollars. Our condensed interim consolidated financial statements, and the financial information contained herein, are reported in thousands of Canadian dollars, except share and per share amounts or as otherwise stated.

Certain information and footnote disclosures normally included in the audited annual consolidated financial statements prepared in accordance with U.S. GAAP have been omitted or condensed. These condensed interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company’s annual report on Form 10-K for the year ended March 31, 2020 (the “Annual Consolidated Financial Statements”), and have been prepared on a basis consistent with the accounting policies as described in the Annual Consolidated Financial Statements.

These condensed interim consolidated financial statements are unaudited and reflect adjustments (consisting of normal recurring adjustments) that are, in the opinion of management, necessary to provide a fair statement of results for the interim periods in accordance with U.S. GAAP.

The results reported in these condensed interim consolidated financial statements should not be regarded as necessarily indicative of results that may be expected for an entire fiscal year. The policies set out below are consistently applied to all periods presented, unless otherwise noted.

(i) Principles of consolidation

The accompanying condensed interim consolidated financial statements include the accounts of the Company and all entities in which the Company either has a controlling voting interest or is the primary beneficiary of a variable interest entity. All intercompany accounts and transactions have been eliminated on consolidation. Information on the Company’s subsidiaries with noncontrolling interests is included in Note 20.

(ii) Variable interest entities

A variable interest entity (“VIE”) is an entity that does not have sufficient equity at risk to finance its activities without additional subordinated financial support or is structured such that equity investors lack the ability to control the entity’s activities or do not substantially participate in the gains and losses of the entity. Upon inception of a contractual agreement, and thereafter, if a reconsideration event occurs, the Company performs an assessment to determine whether the arrangement contains a variable interest in an entity and whether that entity is a VIE. The primary beneficiary of a VIE is the party that has both the power to direct the activities that most significantly impact the VIE’s economic performance and the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. Under Accounting Standards Codification (“ASC”) 810 – Consolidations, where the Company concludes that it is the primary beneficiary of a VIE, the Company consolidates the accounts of that VIE.

Page 5

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

(iii) Equity method investments

Investments accounted for using the equity method include those investments where the Company (i) can exercise significant influence over the other entity and (ii) holds common stock and/or in-substance common stock of the other entity. Under the equity method, investments are carried at cost, and subsequently adjusted for the Company’s share of net income (loss), comprehensive income (loss) and distributions received from the investee. If the current fair value of an investment falls below its carrying amount, this may indicate that an impairment loss should be recorded. Any impairment losses recognized are not reversed in subsequent periods. Refer to Note 8 for additional information on the Company’s investments accounted for using the equity method.

(iv) Use of estimates

The preparation of these condensed interim consolidated financial statements and accompanying notes in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ from those estimates.

(v) New accounting policies

(a) Recently adopted accounting pronouncements

Leases

In February 2016, the Financial Accounting Standards Board (“FASB”) issued new guidance on the recognition and measurement of leases, ASC 842—Leases. Under this guidance, a lessee recognizes assets and liabilities on its balance sheet for most leases. Lease expense continues to be consistent with previous guidance. Additionally, this guidance requires enhanced disclosures regarding the amount, timing, and uncertainty of cash flows arising from leasing arrangements.

The Company adopted the guidance on April 1, 2019, using the modified retrospective approach and, accordingly, prior period balances and disclosures have not been restated. The Company elected the package of transition practical expedients for expired or existing contracts, which retains prior conclusions reached on lease identification, classification, and initial direct costs incurred.

The adoption of this guidance resulted in the recognition of operating lease right-of-use assets of $99,880, net of lease provisions of $10,703 and $110,583 of lease liabilities, with a $nil impact on deficit. The transition to ASC 842 did not have a material impact on the Company’s results of operations or liquidity. When measuring lease liabilities, the Company used its incremental borrowing rate of April 1, 2019 of 4.5%. Further information is disclosed in Note 27.

Revenues

In May 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), which provides a single comprehensive model for accounting for revenue from contracts with customers and supersedes nearly all previously existing revenue recognition guidance. The core principle of ASU 2014-09 is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Canopy Growth adopted the new standard as of April 1, 2018. There was no impact of adopting ASU 2014-09 on the condensed interim consolidated financial statements.

Financial Instruments

In January 2016, the FASB issued ASU 2016-01, Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities, which provides new guidance for the recognition, measurement, presentation, and disclosure of financial assets and liabilities. Canopy Growth adopted the standard on April 1, 2018. Under the new standard, changes in the fair value of equity investments with readily determinable fair values are recorded in other (income) expense, net within the condensed interim consolidated statement of operations. Previously, such fair value changes were recorded in other comprehensive income (loss). The impact of this transition is a cumulative-effect adjustment to deficit of $34,800.

Canopy Growth has elected to continue to measure its equity investments without readily determinable fair values at fair value. Changes in the measurement of these investments will continue to be recorded in other (income) expense, net within the condensed interim consolidated statement of operations.

Page 6

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

Income taxes

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory (“ASU 2016-16”), which requires the recognition of the income tax effects of intercompany sales and transfers of assets, other than inventory, in the period in which the transfer occurs. Canopy Growth adopted the standard on April 1, 2018, using a modified retrospective approach. There was minimal impact of adopting ASU 2016-16 on the condensed interim consolidated financial statements.

(b) Accounting guidance not yet adopted

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. Adoption of ASU 2016-13 will require financial institutions and other organizations to use forward-looking information to better formulate their credit loss estimates. In addition, ASU 2016-13 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. ASU 2016-13 will be effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company is evaluating the impact on the consolidated financial statements and expects to implement the provisions of ASU 2016-13 effective April 1, 2020.

In August 2018, the FASB issued ASU 2018-13, Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820) (“ASU 2018-13”). ASU 2018-13 adds, modifies, and removes certain fair value measurement disclosure requirements. ASU 2018-13 is effective for annual and interim periods beginning after December 15, 2019. Early adoption is permitted. The Company is evaluating the impact on the consolidated financial statements and expects to implement the provisions of ASU 2018-13 effective April 1, 2020.

3. CASH AND CASH EQUIVALENTS

Cash and cash equivalents are disaggregated as follows:

	September 30, 2019		March 31, 2019
Cash	$	492,804	$	1,703,550
Cash equivalents		609,660		777,280
Total cash and cash equivalents	$	1,102,464	$	2,480,830

4. SHORT-TERM INVESTMENTS

The components of short-term investments are as follows:

	September 30, 2019		March 31, 2019
U.S. government securities	$	1,270,819	$	1,663,245
Term deposits		268,323		1,600
Canadian government securities		94,550		369,288
Total short-term investments	$	1,633,692	$	2,034,133

The amortized cost of short-term investments at September 30, 2019 is $1,633,123 (March 31, 2019 – $2,032,770).

Page 7

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

5. AMOUNTS RECEIVABLE, NET

Amounts receivable, net is comprised of:

	September 30,		March 31,
	2019		2019
Accounts receivable, net	$	55,442	$	61,830
Indirect taxes receivable		39,886		27,805
Interest receivable		8,696		7,193
Other receivables		3,463		10,146
Total amounts receivable	$	107,487	$	106,974

Included in the accounts receivable, net balance at September 30, 2019 is an allowance for doubtful accounts of $272 (March 31, 2019—$635).

6. INVENTORY

Inventory is comprised of the following items:

	September 30,		March 31,
	2019		2019
Raw materials	$	39,049	$	845
Work-in-process		240,537		109,672
Finished goods		35,998		30,054
Supplies and consumables		30,929		49,501
Total inventory	$	346,513	$	190,072

The Company recorded write-downs related to inventory in the three and six months ended September 30, 2019 of $21,747 and $26,536, respectively.

7. PREPAID EXPENSES AND OTHER ASSETS

The Company’s prepaid expenses and other assets consists of the following:

	September 30,		March 31,
	2019		2019
Prepaid expenses	$	70,372	$	26,339
Deposits		16,515		29,138
Prepaid inventory		29,370		21,267
Other assets		1,854		8,947
Total prepaid expenses and other assets	$	118,111	$	85,691

Page 8

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

8. EQUITY METHOD INVESTMENTS

The following table outlines changes in the investments in associates that are accounted for using the equity method. Where the Company does not have the same reporting date as its investees, the Company will account for its investments one quarter in arrears. Accordingly, certain of the figures in the following table, including the Company’s share of the investee’s net income (loss), are based on the investees’ results for the period ended June 30, 2019, with adjustments for any significant transactions.

Entity	Instrument		Participating share			Balance at March 31, 2019		Additions		Share of net loss			Balance at September 30, 2019
PharmHouse		Shares		49.0	%	$	39,278	$	—	$	(695	)	$	38,583
Agripharm		Shares		40.0	%		36,127		—		(1,593	)		34,534
Beckley Canopy Therapeutics		Shares		42.2	%		11,653		—		(385	)		11,268
CanapaR		Shares		49.1	%		18,062		—		(259	)		17,803
Other		Shares		18.2% to 66.7	%		7,265		4,665		(1,072	)		10,858
						$	112,385	$	4,665	$	(4,004	)	$	113,046

Page 9

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

9. OTHER FINANCIAL ASSETS

The following tables outlines changes in Other financial assets. Additional details on how the fair value of significant investments is calculated are included in Note 21.

Entity	Instrument	Note			Balance at March 31, 2019		Additions		FVTPL			Interest income		Exercise of options / disposal of shares / repayments			Balance at September 30, 2019
Acreage	Option		26		$	—	$	395,190	$	(235,190	)	$	—	$	—		$	160,000
TerrAscend	Exchangeable shares					160,000		—		(60,000	)		—		—			100,000
PharmHouse	Loan receivable					40,000		—		—			—		—			40,000
Agripharm	Royalty interest					10,254		8,000		1,292			—		—			19,546
ZeaKal	Shares		9	(i)		—		13,487		(245	)		—		—			13,242
Greenhouse	Convertible debenture					5,944		3,000		1,947			—		—			10,891
SLANG	Warrants					44,000		—		(33,000	)		—		—			11,000
Other - classified as fair value through net income (loss)	Various					72,144		5,908		(13,634	)		—		(1,201	)		63,217
Other - elected as fair value through net income (loss)	Various					29,236		1,200		(7,182	)		—		(3,635	)		19,619
Other - classified as held for investment	Loan receivable					1,849		9,650		—			92		(78	)		11,513
					$	363,427	$	436,435	$	(346,012	)	$	92	$	(4,914	)	$	449,028

(i) On June 14, 2019, Canopy Rivers acquired 248,473 preferred shares of ZeaKal, Inc. (“ZeaKal”), a California-based plant science company, for $13,487 which represents a 9% equity interest on a fully diluted basis.

Page 10

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

10. PROPERTY, PLANT AND EQUIPMENT

The components of property, plant and equipment are as follows:

	September 30, 2019			March 31, 2019
Buildings and greenhouses	$	543,855		$	361,958
Production and warehouse equipment		212,222			175,325
Leasehold improvements		46,757			32,264
Land		58,407			37,681
Office and lab equipment		28,336			23,495
Computer equipment		25,256			19,228
Right-of-use assets
Buildings and greenhouses		106,071			—
Production and warehouse equipment		927			—
Assets in process		694,744			491,722
		1,716,575			1,141,673
Less: Accumulated depreciation		(78,112	)		(45,333	)
Total	$	1,638,463		$	1,096,340

Depreciation expense included in cost of goods sold for the three and six months ended September 30, 2019 is $12,138 and $21,455, respectively (three and six months ended September 30, 2018 – $5,674 and $8,926, respectively). Depreciation expense included in selling, general and administrative expenses for the three and six months ended September 30, 2019 is $4,087 and $8,358, respectively (three and six months ended September 30, 2018 – $1,111 and $1,520, respectively).

11. INTANGIBLE ASSETS

The components of intangible assets are as follows:

	September 30, 2019				March 31, 2019
	Gross Carrying Amount		Net Carrying Amount		Gross Carrying Amount		Net Carrying Amount
Finite lived intangible assets
Licensed brands	$	68,432	$	64,754	$	57,802	$	57,678
Distribution channel		42,446		21,259		42,400		25,297
Health Canada and operating licenses		104,967		98,911		104,608		99,587
Intellectual property		151,634		141,254		153,797		149,360
Software and domain names		13,282		9,273		9,701		6,819
Amortizable intangibles in process		4,637		4,561		4,122		4,046
Total		385,398		340,012		372,430		342,787
Indefinite lived intangible assets
Operating licenses				151,509				151,509
Acquired brands				62,934				63,774
Total intangible assets			$	554,455			$	558,070

Amortization expense included in cost of goods sold for the three and six months ended September 30, 2019 is $26 and $38, respectively (three and six months ended September 30, 2018 – $25 and $35, respectively). Amortization expense included in selling, general and administrative expenses for the three and six months ended September 30, 2019 is $8,764 and $15,917, respectively (three and six months ended September 30, 2018 – $2,579 and $5,201, respectively).

Page 11

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

12. GOODWILL

The net change in goodwill is as follows:

	Note
As at March 31, 2018			$	277,445
Purchase accounting allocations				1,215,750
Foreign currency translation adjustments				(3,336	)
As at March 31, 2019			$	1,489,859
Purchase accounting allocations		25		388,586
Foreign currency translation adjustments				(20,157	)
As at September 30, 2019			$	1,858,288

13. OTHER ACCRUED EXPENSES AND LIABILITIES

The components of other accrued expenses and liabilities are as follows:

	September 30, 2019		March 31, 2019
Property, plant and equipment	$	6,890	$	8,013
Professional fees		930		2,059
Employee compensation		23,118		20,577
Other		6,328		6,964
Total accounts payable and accrued liabilities	$	37,266	$	37,613

14. DEBT

The components of debt are as follows:

			September 30,			March 31,
	Maturity Date		2019			2019
Convertible senior notes at 4.25% interest with semi-annual interest payments		July 15, 2023
Principal amount			$	600,000		$	600,000
Accrued interest				5,454			5,454
Non-credit risk fair value adjustment (FVTPL)				(25,470	)		183,120
Credit risk fair value adjustment (FVOCI)				10,470			47,130
				590,454			835,704
Term loan facility advanced in the form of prime rate operating loan			$	—		$	95,000
Transferred receivables, bearing interest rate of EURIBOR plus 0.850%				2,924			—
Other revolving debt facility, loan, and financings				11,110			15,271
				604,488			945,975
Less: current portion				(14,115	)		(103,716	)
Long-term portion			$	590,373		$	842,259

Page 12

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

(i) Convertible senior notes

On June 20, 2018, the Company issued convertible senior notes (“the notes”) with an aggregate principal amount of $600,000. The notes are subordinated in right of payment to any existing and future senior indebtedness, including indebtedness under the revolving credit facility. The notes will rank senior in right of payment to any future subordinated borrowings.

Holders of the notes have the right to exercise the conversion option at a rate of 20.7577 common shares for every $1 of principal amount of notes from September 30, 2018 to January 15, 2023, if (i) the market price of the Company common shares for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day, (ii) during the 5 business day period after any consecutive 5 trading day period (the “measurement period”) in which the trading price per $1 principal amount of the notes for each trading day in the measurement period was less than 98% of the product of the last reported sales price of the Company’s common shares and the conversion rate on each such trading day, (iii) the notes are called for redemption or (iv) upon occurrence of certain corporate events (“Fundamental Change”).

The Company may also redeem the notes if certain tax laws related to Canadian withholding tax change subject to certain further conditions. The redemption of the notes shall be at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest.

The overall change in fair value of the notes during the three and six months ended September 30, 2019 was a decrease of $199,194 and $245,250 respectively (three and six months ended September 30, 2018 – $288,984 and $301,224), which included accrued contractual interest of $6,306 and $12,750 respectively (three and six months ended September 30, 2018 – $990 and $7,224). Refer to Note 21 for additional details on how the fair value of the notes is calculated.

(ii) Alberta Treasury Board (“ATB”) financing

On June 14, 2019, the Company repaid its ATB term loan facility. A payment of $95,180 was made to settle the loan balance which included interest of $180.

(iii) Transferred receivables

The carrying amounts of the transferred receivables include receivables which are subject to a factoring arrangement. Under this arrangement, C³ has transferred the relevant receivables to PB Factoring GmbH in exchange for cash. The transferred receivables to PB Factoring GmbH is $3,249 and the associated secured borrowing is $2,924.

(iv) Other revolving debt facility, loans, and financings

The revolving debt facility is secured by a first charge on the properties in Niagara-on-the-Lake, Ontario, a corporate guarantee from the Company, and a general corporate security agreement.

15. OTHER LIABILITIES

The components of other liabilities are as follows:

				September 30, 2019						March 31, 2019
	Notes			Current		Long-term		Total		Current		Long-term		Total
Acquisition consideration related liabilities				$	25,616	$	81,591	$	107,207	$	22,176	$	87,747	$	109,923
Lease liabilities		27			53,621		65,402		119,023		—		—		—
Minimum royalty obligations					6,308		22,069		28,377		3,445		24,392		27,837
Due to former shareholders of Storz & Bickel					—		—		—		21,447		—		21,447
Refund liability		22			37,790		—		37,790		—		—		—
Settlement liability		15	(a)		5,347		9,824		15,171		11,980		16,631		28,611
Other					14,134		4,067		18,201		22,366		5,234		27,600
Total				$	142,816	$	182,953	$	325,769	$	81,414	$	134,004	$	215,418

Page 13

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

(a) Settlement liability

During the year ended March 31, 2019, the Company reached a settlement with certain co-investors in Bedrocan Brasil S.A. and Entourage Phytolab S.A. to facilitate organizational changes to support the Company’s growth in Latin America. Under the terms of the agreement the Company agreed to make cash payments totaling $25,185 and a final payment equal to 1.2% of the fair value of the Company’s Latin American business as of June 30, 2023. The fair value of the settlement was estimated to be $28,611 and was recorded as an expense. The final payment represents a derivative liability that was initially measured at fair value with subsequent period end remeasurements of fair value recorded through net income (loss).

During the three and six months ended September 30, 2019, payments totalling $5,600 and $13,908 respectively, were made, with the remaining change in liability relating to accretion expense and fair value changes.

16. REDEEMABLE NONCONTROLLING INTEREST

The net change in the redeemable noncontrolling interests is as follows:

	Vert Mirabel
As at March 31, 2019	$	6,400
Income attributable to noncontrolling interest		3,679
Adjustments to redemption amount		(779	)
As at September 30, 2019	$	9,300

	Vert Mirabel			BC Tweed			Total
As at March 31, 2018	$	4,850		$	56,300		$	61,150
Income attributable to noncontrolling interest		(1,810	)		—			(1,810	)
Adjustments to redemption amounts		4,460			16,300			20,760
Purchase of redeemable noncontrolling interest		—			(72,600	)		(72,600	)
As at September 30, 2018	$	7,500		$	—		$	7,500

Page 14

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

17. SHARE CAPITAL

CANOPY GROWTH

Authorized

An unlimited number of common shares.

(i) Equity financings

There were no equity financings during the six months ended September 30, 2019.

(ii) Other issuances of common shares

During the three and six months ended September 30, 2019, the Company issued 84,530 and 566,851 (three and six months ended September 30, 2018 – 19,167,538 and 20,494,376) shares with an increase of $3,041 and $21,715 (three and six months ended September 30, 2018 – $930,063 and $968,256) in share capital respectively.

(iii) Warrants

	Note		Number of whole warrants			Average exercise price		Warrant value
Balance outstanding at March 31, 2019				107,848,322		$	43.80	$	1,589,925
Tranche A warrant modification		26		—			—		1,049,153
Issuance of Tranche B warrants		26		38,454,444			76.68		—
Other issuance of warrants				9,200			32.83		359
Exercise of warrants				(12,523	)		35.55		(486	)
Balance outstanding at September 30, 20191				146,299,443		$	52.44	$	2,638,951

¹  This balance excludes the Tranche C Warrants, which represent a derivative liability and have nominal value, see note 26.

CANOPY RIVERS

(a) Authorized

Canopy Rivers Corporation (“Canopy Rivers”) is authorized to issue an unlimited number of common shares. There are two classes of common shares: Multiple Voting Shares and Subordinated Voting Shares. Each Multiple Voting Share is entitled to receive 20 votes, while each Subordinated Voting Share is entitled to receive one vote at all meetings of the shareholders. There is no priority or distinction between the two classes of shares in respect of their entitlement to the payment of dividends or participation on liquidation, dissolution or winding-up of the Company.

(b) Issued and outstanding

As at September 30, 2019, Canopy Rivers had 36,468,318 Multiple Voting Shares (March 31, 2019 – 36,468,318) and 151,731,576 Subordinated Voting Shares (March 31, 2019 – 150,592,136) issued and outstanding. As at September 30, 2019, the Company held 36,468,318 Multiple Voting Shares (March 31, 2019 – 36,468,318) and 15,223,938 Subordinated Voting shares (March 31, 2019 – 15,223,938) which represented a 27.5% ownership interest in Canopy Rivers and 84.5% of the voting rights (March 31, 2019 – 27.6% and 84.6% respectively). The voting rights allow the Company to direct the relevant activities of Canopy Rivers such that the Company has control over Canopy Rivers and Canopy Rivers is consolidated in these financial statements.

Page 15

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

(c) Financings

There were no financings during the six months ended September 30, 2019, other than the release of shares related to share purchase financing

(d) Initial financing and seed capital options

The 10,066,668 Subordinated Voting Shares acquired by way of share purchase loans, whereby funds were advanced to Canopy Rivers by the Company on behalf of certain employees of the Company and another individual, were initially accounted for as seed capital options and are not considered issued for accounting purposes until the loans are repaid on an individual employee/consultant basis. During the three and six months ended September 30, 2019, share purchase loans in the amount of $29 and $48 respectively (three and six months ended September 30, 2018 – $nil and $288 respectively) relating to Canopy Rivers shares held in trust by the Company on behalf of certain Canopy Growth employees were repaid, resulting in the release from escrow of Subordinated Voting Shares of 583,333 and 961,108 respectively (three and six months ended September 30, 2018 – nil and 5,750,000 respectively). As at September 30, 2019, there were 2,877,784 seed capital options outstanding (March 31, 2019 – 3,838,892).

18. SHARE BASED COMPENSATION

CANOPY GROWTH CORPORATION SHARE-BASED COMPENSATION PLAN

Canopy Growth’s eligible employees participate in a share-based compensation plan as noted below.

On September 15, 2017, shareholders approved an Omnibus Incentive Plan (as amended and restated, the “Omnibus Plan”) pursuant to which the Company can issue share-based long-term incentives. All directors, officers, employees and independent contractors of the Company are eligible to receive awards of common share purchase options (“Options”), restricted share units (“RSUs”), deferred share units, stock appreciation rights (“Stock Appreciation Rights”), performance awards (“Performance Awards”) or other stock based awards (collectively, the “Awards”) under the Omnibus Plan. In addition, shareholders also approved the 2017 Employee Stock Purchase Plan of the Company (the “Purchase Plan”). Under the Purchase Plan, the aggregate number of common shares that may be issued is 400,000, and the maximum number of common shares which may be issued in any one fiscal year shall not exceed 200,000.

Under the Omnibus Plan, the maximum number of shares issuable from treasury pursuant to Awards shall not exceed 15% of the total outstanding shares from time to time less the number of shares issuable pursuant to all other security-based compensation arrangements of the Company. The maximum number of common shares reserved for Awards is 52,249,177 at September 30, 2019. As of September 30, 2019, the only Awards issued have been options and RSUs under the Omnibus Plan.

The Omnibus Plan is administered by the Board of Directors of the Company who establishes exercise prices, at not less than the market price at the date of grant, and expiry dates. Options under the Omnibus Plan generally remain exercisable in increments with 1/3 being exercisable on each of the first, second and third anniversaries from the date of grant, with expiry dates set at six years from issuance. The Board of Directors has the discretion to amend general vesting provisions and the term of any award, subject to limits contained in the Omnibus Plan.

The following is a summary of the changes in the Company’s Omnibus Plan employee options during the six months ended September 30, 2019:

	Options issued			Weighted average exercise price
Balance outstanding at March 31, 2019		32,831,895		$	34.10
Options granted		5,327,689			41.74
Options exercised		(3,290,212	)		10.95
Options forfeited/cancelled		(1,956,398	)		45.84
Balance outstanding at September 30, 2019		32,912,974		$	36.95

Page 16

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

The following is a summary of the outstanding stock options as at September 30, 2019:

	Options Outstanding				Options Exercisable
Range of Exercise Prices	Outstanding at September 30, 2019		Weighted Average Remaining Contractual Life (years)		Exercisable at September 30, 2019		Weighted Average Remaining Contractual Life (years)
$1.32 - $27.94		6,155,483		3.56		2,888,874		3.30
$27.95 - $35.00		3,666,663		4.78		609,686		4.41
$35.01 - $38.88		7,815,201		5.29		500,000		5.23
$38.89 - $42.84		6,267,481		4.89		1,439,214		4.56
$42.85 - $67.64		9,008,146		5.42		853,363		4.99
		32,912,974		4.87		6,291,137		4.08

At September 30, 2019, the weighted average exercise price of options outstanding and options exercisable was $36.95 and $27.81, respectively (at March 31, 2019 – $34.10 and $13.99, respectively).

For the three and six months ended September 30, 2019, the Company recorded $79,163 and $149,979 in share-based compensation expense related to options issued to employees (for the three and six months ended September 30, 2018 – $31,312, and $44,859) and $1,062 and $3,339, respectively, in share-based compensation expense related to options issued to contractors (for the three and six months ended September 30, 2018 – $2,313, and $2,910). The compensation expense for the six months ended September 30, 2019 includes an amount related to 445,000 options being provided in exchange for services which are subject to performance conditions (for the six months ended September 30, 2018 – 422,974).

In determining the amount of share-based compensation related to options issued during the period, the Company used the Black-Scholes option pricing model to establish the fair value of options granted during the three months ended September 30, 2019 and 2018 on their measurement date by applying the following assumptions:

	September 30, 2019			September 30, 2018
Risk-free interest rate		1.44	%		2.18	%
Expected life of options (years)		3 - 5			2 - 5
Expected annualized volatility		72	%		76	%
Expected forfeiture rate		11	%		11	%
Expected dividend yield		nil			nil
Black-Scholes value of each option	$	22.57		$	29.13

Volatility was estimated by using the historical volatility of the Company. The expected life in years represents the period of time that options granted are expected to be outstanding. The risk-free rate was based on the zero coupon Canada government bonds with a remaining term equal to the expected life of the options.

During the six months ended September 30, 2019, 3,290,212 Omnibus Plan options were exercised ranging in price from $0.22 to $40.68 for gross proceeds of $36,023 (for the six months ended September 30, 2018 –3,844,191 Omnibus Plan options were exercised ranging in price from $1.32 to $27.99 for gross proceeds of $24,893).

During the three and six months ended September 30, 2019, the Company issued nil RSUs. As at September 30, 2019, the Company had 141,630 RSUs issued and outstanding, of which 17,820 were exercisable. For the three and six months ended September 30, 2019, the Company recorded $1,287 and $2,681 respectively, in share-based compensation expense related to these RSUs (for the three and six months ended September 30, 2018 – $428 and $2,675).

Page 17

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

Share-based compensation expense related to acquisition milestones is comprised of:

	Three months ended				Six months ended
	September 30, 2019		September 30, 2018		September 30, 2019		September 30, 2018
Colombia	$	4,141	$	9,417	$	6,400	$	9,417
Canindica		2,286		29,358		6,296		29,358
Other		2,687		11,955		6,699		19,050
	$	9,114	$	50,730	$	19,395	$	57,825

During the three and six months ended September 30, 2019, 84,530 and 566,851 shares, respectively (three and six months ended September 30, 2018 – 1,637,074 and 1,908,532 respectively) were released on completion of acquisition milestones. At September 30, 2019, there were up to 5,206,438 shares to be issued on the completion of acquisition and asset purchase milestones. In certain cases, the number of shares to be issued is based on the volume weighted average share price at the time the milestones are met. The number of shares has been estimated assuming the milestones were met at September 30, 2019. The number of shares excludes shares to be issued on July 4, 2023 to the previous shareholders of Spectrum Cannabis Colombia S.A.S. (“Spectrum Colombia”) and Canindica Capital Ltd. (“Canindica”) based on the fair market value of the Company’s Latin American business on that date.

During the three and six months ended September 30, 2019, the Company recorded share-based payments of $nil (three and six months ended September 30, 2018 – $3,801 and $4,585 respectively), related to shares issued for payment of royalties and sales and marketing services.

CANOPY RIVERS SHARE-BASED COMPENSATION PLAN

Seed Capital Options

On May 12, 2017, seed capital options were issued. These seed capital options consistent of 10,066,668 Class B shares acquired by way of share purchase loans. Since they were issued through loans, they are not considered issued for accounting purposes until the loans are repaid. The seed capital options were measured at fair value on May 12, 2017, using a Black-Scholes option pricing model and will be expensed over their vesting period. Where there are performance conditions in addition to service requirements Canopy Rivers has estimated the number of shares it expects to vest and is amortizing the expense over the expected vesting period.

	Seed capital options issued			Seed capital loan balance
Balance outstanding at March 31, 2019		3,838,892		$	192
Options exercised		(961,108	)		(48	)
Balance outstanding at September 30, 2019		2,877,784		$	144

Canopy Rivers has a stock option plan (the “Plan”) under which non-transferable options to purchase Subordinated Voting Shares of the Company may be granted to directors, officers, employees, or independent contractors of the Company. Pursuant to the Plan, the maximum number of Subordinated Voting Shares issuable from treasury pursuant to outstanding options shall not exceed 10% of the issued and outstanding Subordinated Voting Shares. The Plan is administered by the Board who establishes exercise prices, at not less than the market price at the date of the grant, and expiry dates. Options under the Plan generally remain exercisable in increments, with one-third being exercisable on each of the first, second, and third anniversaries from the date of grant, and have expiry dates five years from the date of grant. The Board has the discretion to amend general vesting provisions and the term of any option grant, subject to limits contained in the Plan. The seed capital options are not within the scope of the Plan.

Page 18

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

The following is a summary of the changes in Canopy Rivers’ stock options, excluding the seed capital options presented separately, during the six months ended September 30, 2019:

	Options issued			Weighted average exercise price
Balance outstanding at March 31, 2019		12,522,255		$	1.98
Options granted		1,703,000			3.76
Options exercised		(178,332	)		0.60
Balance outstanding at September 30, 2019		14,046,923		$	2.21

In determining the amount of share-based compensation related to options issued during the period, Canopy Rivers used the Black-Scholes option pricing model to establish the fair value of options granted during the three months ended September 30, 2019 and 2018 on their measurement date by applying the following assumptions:

	September 30, 2019			September 30, 2018
Risk-free interest rate		1.41	%		2.02	%
Expected life of options (years)		3 - 4			3 - 5
Expected annualized volatility		70	%		70	%
Expected forfeiture rate		nil			nil
Expected dividend yield		nil			nil
Black-Scholes value of each option	$	1.23		$	1.53

Volatility was estimated using companies that Canopy Rivers considers comparable that have trading and volatility history prior to Canopy Rivers becoming public. The expected life in years represents the period of time that options granted are expected to be outstanding. The risk-free rate was based on zero coupon Canada government bonds with a remaining term equal to the expected life of the options.

For the three and six months ended September 30, 2019, the Company recorded $2,255 and $4,849 respectively, (three and six months ended September 30, 2018 – $1,771 and $3,853) in share-based compensation expense related to these options and the seed capital options with a corresponding increase to non-controlling interests.

19. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

Accumulated other comprehensive income (loss) includes the following components:

	Foreign currency translation adjustments			Changes of own credit risk of financial liabilities			Accumulated other comprehensive income (loss)
Balance at March 31, 2019	$	41,225		$	(47,130	)	$	(5,905	)
Other comprehensive income (loss)		(52,117	)		36,660			(15,457	)
Balance at September 30, 2019	$	(10,892	)	$	(10,470	)	$	(21,362	)

	Foreign currency translation adjustments			Changes of own credit risk of financial liabilities			Fair value of other financial assets			Accumulated other comprehensive income (loss)
Balance at March 31, 2018	$	608		$	—		$	34,800		$	35,408
Cumulative effect from adoption of ASU2016-1		—			—			(34,800	)		(34,800	)
Other comprehensive (loss) income		(4,706	)		(75,030	)		—			(79,736	)
Balance at September 30, 2018	$	(4,098	)	$	(75,030	)	$	—		$	(79,128	)

Page 19

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

20. NONCONTROLLING INTERESTS

The net change in the noncontrolling interests is as follows:

	Canopy Rivers			Vert Mirabel			Other non- material interests		Total
As at March 31, 2019	$	280,012		$	2,422		$	3,051	$	285,485
Comprehensive (loss) income		(30,214	)		5,764			—		(24,450	)
Net loss attributable to redeemable noncontrolling interest		—			(3,679	)		—		(3,679	)
Share-based compensation		4,849			—			—		4,849
Ownership changes		490			—			—		490
As at September 30, 2019	$	255,137		$	4,507		$	3,051	$	262,695

21. FAIR VALUE OF FINANCIAL INSTRUMENTS

(a) Fair value of financial instrument assets and liabilities that are measured at fair value on a recurring basis

The following table summarizes the valuation techniques and key inputs used in the fair value measurement of significant level 2 financial instruments:

Financial asset / financial liability	Valuation techniques	Key inputs
AusCann Group Holdings options	Black-Scholes option pricing model	Quoted prices in active market
Convertible senior note	Convertible note pricing model	Quoted prices in over-the-counter broker market

Page 20

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

The following table summarizes the valuation techniques and significant unobservable inputs in the fair value measurement of significant level 3 financial instruments:

Financial asset / financial liability	Valuation techniques	Significant unobservable inputs	Relationship of unobservable inputs to fair value
Acreage financial instrument	Discounted cash flow	Intrinsic value of Acreage	Increase or decrease in intrinsic value will result in an increase or decrease in fair value
		Probability and timing of US legalization	Increase or decrease in probability of US legalization will result in an increase or decrease in fair value
		Estimated premium on US legalization	Increase or decrease in estimated premium on US legalization will result in an increase or decrease in fair value
		Control premium	Increase or decrease in estimated control premium will result in an increase or decrease in fair value
		Synergy value to Canopy Growth	Increase or decrease in estimated synergy value to Canopy Growth will result in an increase or decrease in fair value
TerrAscend exchangeable shares	Put option pricing model	Probability and timing of US legalization	Increase or decrease in probability of US legalization will result in an increase or decrease in fair value
HydRx Farms shares	Market approach	Share price	Increase or decrease in share price will result in an increase or decrease in fair value
ZeaKal shares	Market approach	Share price	Increase or decrease in share price will result in an increase or decrease in fair value
Greenhouse convertible debenture	FinCAD model	Share price	Increase or decrease in share price will result in an increase or decrease in fair value
Good Leaf shares	Market approach	Share price	Increase or decrease in share price will result in an increase or decrease in fair value
Agripharm royalty interest and repayable debenture	Discounted cash flow	Discount rate	Increase or decrease in discount rate will result in a decrease or increase in fair value
		Future royalties	Increase in future royalties to be paid will result in an increase in fair value
SLANG Worldwide warrant	Black-Scholes option pricing model	Probability and timing of US legalization	Increase or decrease in probability of US legalization will result in an increase or decrease in fair value
Warrant derivative liability	Monte Carlo simulation model	Volatility of Canopy Growth share price	Increase or decrease in volatility will result in an increase or decrease in fair value
		Expected life	Increase or decrease in expected life will result in an increase or decrease in fair value
Vert Mirabel redeemable noncontrolling interest	Discounted cash flow	Discount rate	Increase or decrease in discount rate will result in a decrease or increase in fair value
		Future wholesale price and production levels	Increase in future wholesale price and production levels will result in an increase in fair value

Page 21

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

During the six months ended September 30, 2019 and September 30, 2018, there were no transfers of amounts between levels.

(b) Fair value of financial instrument assets and liabilities that are not measured at fair value but fair value disclosures are required

The carrying values of cash and cash equivalents, short-term investments, accounts payable and other accrued expenses and liabilities approximate their fair values due to their short-term to maturity.

22. REVENUE

Revenues are disaggregated as follows:

	Three months ended				Six months ended
	September 30,		September 30,		September 30,		September 30,
	2019		2018		2019		2018
Recreational revenue
Business to business	$	16,677	$	—	$	67,102	$	—
Business to consumer		13,100		—		23,738		—
Medical revenue
Canadian		14,149		19,903		27,200		41,267
International		18,090		2,222		28,586		5,592
Other revenue		23,605		1,202		42,386		2,384
Gross revenue		85,621		23,327		189,012		49,243
Excise taxes		9,008		—		21,917		—
Net revenue	$	76,613	$	23,327	$	167,095	$	49,243

The Company records an allowance for estimated returns and price adjustments to ensure that recognized revenue reflects the consideration that the Company expects to receive. The allowance is based on historical experience and Management’s expectation of future returns and price adjustments. Net revenue reflects actual returns and the allowance for estimated returns and price adjustments in the amounts of $32,727 and $40,727 for the three and six months ended September 30, 2019, respectively (three and six months ended September 30, 2018 – $nil). As of September 30, 2019, the liability for estimated returns and price adjustments was $37,790 (March 31, 2019 – $nil).

Page 22

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

23. OTHER INCOME (EXPENSE), NET

Other income (expense), net is disaggregated as follows:

			Three months ended						Six months ended
			September 30,			September 30,			September 30,			September 30,
	Notes		2019			2018			2019			2018
Fair value changes on other financial assets		9	$	(69,735	)	$	44,773		$	(110,822	)	$	36,583
Fair value changes on asset arising from Acreage Arrangement		9, 26		(235,190	)		—			(235,190	)		—
Fair value changes on convertible senior notes		14		164,394			(223,374	)		195,840			(226,194	)
Fair value change on warrant derivative liability		26		641,854			—			666,746			—
Fair value changes on acquisition related contingent consideration				(70	)		—			(1,640	)		—
Interest income				16,463			2,546			39,181			3,552
Interest expense				(1,165	)		(192	)		(2,371	)		(348	)
Foreign currency loss				(5,553	)		(704	)		(8,409	)		(2,957	)
Gain on acquisition of consolidated entity				—			62,682			—			62,682
Debt issuance costs				—			(335	)		—			(16,380	)
Other income (expense), net				(1,105	)		1,457			(674	)		(1,254	)
Total other income (expense), net			$	509,893		$	(113,147	)	$	542,661		$	(144,316	)

24. INCOME TAXES

There have been no material changes to income tax matters in connection with normal course operations during the six months ended September 30, 2019.

The Company is subject to income tax in numerous jurisdictions with varying income tax rates. During the most recent period ended and the fiscal year to date, there were no material changes to the statutory income tax rates in the taxing jurisdictions where the majority of the Company’s income for tax purposes was earned, or where its temporary differences or losses are expected to be realized or settled. Although statutory income tax rates remain stable, the Company’s effective income tax rate may fluctuate, arising as a result of the Company’s evolving footprint, discrete transactions and other factors that, to the extent material, are disclosed in these financial statements.     

The Company continues to believe the amount of unrealized tax benefits appropriately reflects the uncertainty of items that are or may in the future be under discussion, audit, dispute or appeal with a tax authority or which otherwise result in uncertainty in the determination of income for tax purposes. If appropriate, an unrealized tax benefit will be realized in the reporting period in which the Company determines that realization is not in doubt. Where the final determined outcome is different from the Company’s estimate, such difference will impact the Company’s income taxes in the reporting period during which such determination is made.

Page 23

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

25. ACQUISITIONS

Acquisitions completed in the six months ended September 30, 2019

The following table summarizes the consolidated statements of financial position impact on the acquisition date of the Company’s business combinations that occurred in the six months ended September 30, 2019

	C3			This Works
	(i)			(ii)			Total
Cash and cash equivalents	$	2,818		$	1,619		$	4,437
Other current assets		13,326			6,484			19,810
Property, plant and equipment		8,345			478			8,823
Intangible assets
Brands		10,229			2,319			12,548
Intellectual property		—			164			164
Software and domain names		8			176			184
Goodwill		322,334			66,252			388,586
Accounts payable and other accrued expenses and liabilities		(4,454	)		(5,691	)		(10,145	)
Debt and other liabilities		(3,942	)		—			(3,942	)
Net assets acquired	$	348,664		$	71,801		$	420,465
Consideration paid in cash	$	348,664		$	71,801		$	420,465
Other consideration		—			—			—
Total consideration	$	348,664		$	71,801		$	420,465
Consideration paid in cash	$	348,664		$	71,801		$	420,465
Less: Cash and cash equivalents acquired		(2,818	)		(1,619	)		(4,437	)
Net cash outflow	$	345,846		$	70,182		$	416,028

Page 24

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

The table above summarizes the fair value of the consideration given and the fair values assigned to the assets acquired and liabilities assumed for each acquisition. Goodwill arose in these acquisitions because the cost of acquisition included a control premium. In addition, the consideration paid for the combination reflected the benefit of expected revenue growth and future market development. These benefits were not recognized separately from goodwill because they do not meet the recognition criteria for identifiable intangible assets. None of the goodwill arising on these acquisitions is expected to be deductible for tax purposes.

(i) C³

On April 30, 2019, the Company acquired 100% of the shares of C³ Cannabinoid Compound Company (“C³”) for total cash consideration of $348,664. C³ is a European based biopharmaceutical company that develops, manufactures and commercializes natural and synthetic cannabinoid based active ingredients. In connection with the acquisition, the Company entered into a five year cooperation agreement with the former majority shareholder of C³, for which the Company paid $8,694 which will be expensed ratably over the contract term.

Due to the timing of this acquisition, the purchase price allocation for the C³ acquisition is provisional. The fair value assigned to the consideration paid, intangible assets and net assets acquired is based on management’s best estimate using the information currently available and may be revised by the Company as additional information is received.

(ii) This Works

On May 21, 2019, the Company acquired 100% of the shares of TWP UK Holdings Limited (“This Works”) and its subsidiary companies, This Works Products Limited, TWP USA Inc. and TWP IP Limited for total cash consideration of $71,801 (GBP 42,144). Based in London, United Kingdom, This Works is a natural skincare and sleep solutions company.

Due to the timing of this acquisition, the purchase price allocation for the This Works acquisition is provisional. The fair value assigned to the consideration paid, intangible assets and net assets acquired is based on management’s best estimate using the information currently available and may be revised by the Company as additional information is received.

26. ACREAGE TRANSACTIONS

(a) Acreage Arrangement

On June 27, 2019 (the “Effective date”) Canopy Growth and Acreage Holdings, Inc. (“Acreage”) completed a Plan of Arrangement (the “Arrangement”). Pursuant to the terms of the Arrangement, Acreage shareholders and holders of certain securities convertible into Acreage shares as of June 26, 2019, received an immediate aggregate total payment of US$300 million ($395,190) in exchange for granting Canopy Growth both the right and the obligation (the “Acreage financial instrument”) to acquire 100% of the shares of Acreage, at such time as the occurrence or waiver of changes in U.S. federal law to permit the general cultivation, distribution, and possession of marijuana or to remove the regulation of such activities from the federal laws of the United States (the “Acreage Triggering Event”). If the Acreage Triggering Event is not satisfied or waived by December 27, 2026, the Arrangement will terminate.

Following the occurrence, or waiver by Canopy Growth, of the Acreage Triggering Event and the satisfaction or waiver of certain customary closing conditions to the completion of the acquisition, Canopy Growth will issue to the shareholders of Acreage 0.5818 of a common share of Canopy Growth (the “Acreage exchange ratio”) for each issued and outstanding subordinate voting share of Acreage held (following the automatic conversion of other classes of Acreage shares into subordinate voting shares in accordance with the Arrangement). In the event Acreage issues more than 188,235,587 subordinate voting shares on a fully diluted basis, and Canopy Growth has not provided written approval for the issuance of such additional securities, the Acreage exchange ratio shall be the fraction, calculated to six decimal places, determined by the formula of A x B/C where:

• “A” equals 0.5818,

• “B” equals 188,235,587, and

• “C” equals the aggregate number of subordinate voting shares of Acreage on a fully diluted basis at the time of acquisition.

On the Effective Date Canopy Growth also granted Acreage a non-exclusive, non-transferable, royalty-free license and right to use the intellectual property, systems and trademarks in the United States for a period of 90 months. Management has estimated the fair value of this license to be nominal.

Page 25

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

On initial recognition, the Acreage financial instrument represented a financial asset and has been recorded at its fair value of $395,190, as the estimated fair value of the Acreage business is greater than the estimated fair value of the consideration to be provided upon required exercise of the Acreage financial instrument. Any subsequent changes in fair value will be recognized in net income (loss). The fair value determination includes a high degree of subjectivity and judgement, which results in significant estimation uncertainty. See Note 21 for additional details on how the fair value of the Acreage financial instrument is calculated on a recurring basis. From a measurement perspective, Canopy Growth has elected the fair value option under ASC 825.

(b) Amendment to the Constellation Investor Rights Agreement and warrants

On November 1, 2018 Canopy Growth issued 104,500,000 common shares from treasury and two tranches of warrants to a subsidiary of Constellation Brands, Inc. (“Constellation”) in exchange for proceeds of $5,072,500 and entered into an Amended and Restated Investor Rights Agreement. The first tranche warrants (“Tranche A Warrants”) allowed Constellation to acquire 88.5 million additional shares of Canopy Growth for a fixed price of $50.40 per share. The second tranche warrants (“Final Warrants”) allowed for the purchase of 51.3 million additional shares at a price equal to the 5-day volume-weighted average price immediately prior to exercise. The Final Warrants could only be exercised if the Tranche A Warrants had been exercised in full. Both the Tranche A Warrants and the Final Warrants expire on November 1, 2021. Canopy Growth accounted for the Tranche A Warrants as equity instruments with a relative fair value of $1,505,351 and the Final Warrants as equity instruments with a nominal value.

On June 27, 2019 Constellation and Canopy Growth entered into the Second Amended and Restated Investor Rights Agreement and Consent Agreement. In contemplation of these agreements, Canopy Growth also amended the terms of the Tranche A Warrants and Final Warrants as follows:

• Extended the term of the Tranche A Warrants to November 1, 2023 and the term of the Final Warrants to November 1, 2026.

• The Final Warrants were also replaced by two tranches of warrants (the “Tranche B Warrants” and “Tranche C Warrants”) with different terms:

• Tranche B Warrants allow Constellation to acquire 38.5 million shares of Canopy Growth for a fixed price of $76.68 per share.

• Tranche C Warrants allow Constellation to acquire 12.8 million shares of Canopy Growth at a price equal to the 5-day volume-weighted average price immediately prior to exercise.

• In connection with the Tranche B Warrants and the Tranche C Warrants, Canopy Growth will provide Constellation with a share repurchase credit of up to $1.583 billion on the aggregate exercise price of the Tranche B Warrants and Tranche C Warrants in the event that Canopy Growth does not repurchase the lesser of (i) 27,378,866 common shares, and (ii) common shares with a value of $1.583 billion, during the period commencing on June 27, 2019 and ending on the date that is 24 months after the date that Constellation exercises all of the Tranche A Warrants.

The modifications to the Tranche A Warrants resulted in them meeting the definition of a derivative instrument under ASC 815 – Derivatives and Hedging. They continue to be classified in equity as the number of shares and the exercise price were both fixed at inception. The extension of the term of the Tranche A Warrants resulted in additional value being attributed to those warrants. On June 27, 2019 the fair value of the Tranche A Warrants was estimated to be $2,554,503 using a Monte Carlo model and assuming a volatility of 66.7%. The Company recorded a deemed dividend of $1,049,153 in deficit related to the difference between the original and modified Tranche A warrants.

The Tranche B Warrants failed the fixed-for-fixed criterion and, as a result, the Tranche B Warrants are classified as derivative instruments measured at fair value in accordance with ASC 815. On June 27, 2019 the fair value of the Tranche B Warrants was estimated to be $1,117,640 using a Monte Carlo model and assuming a volatility of 66.7%. The value of the Tranche B warrants was recorded directly in deficit as a deemed dividend. Any subsequent changes in fair value will be recorded in net income (loss). As at September 30, 2019, the fair value of the warrant derivative liability is $450,894, and a gain of $666,746 has been recorded during the six months ended September 30, 2019 in Other income (expense), net. The fair value determination includes a high degree of subjectivity and judgement, which results in significant estimation uncertainty. See Note 21 for additional details on how the fair value of the warrant derivative liability is calculated on a recurring basis.

Page 26

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

The Tranche C Warrants are also accounted for as derivative liabilities. Therefore, 12.8 million of the Final Warrants were derecognized and 12.8 million Tranche C Warrants were recognized as new derivative liabilities. The fair values of the Final Warrants and Tranche C Warrants both approximate $nil therefore there was no impact to shareholders’ equity. Any subsequent changes in fair value will be recorded in net income (loss).

The share repurchase credit feature is a derivative liability as Canopy Growth has an obligation to repurchase a variable number of its common shares in order to settle the liability in the future within the share repurchase period or has the option to settle the liability in cash. The fair value of this liability is nominal. The initial value of the derivative liability is a deemed dividend recorded directly in shareholders’ deficit. Any subsequent changes in fair value will be recorded in net income (loss).

27. LEASES

The Company primarily leases office and production facilities, warehouses, production equipment and vehicles. The Company assesses service arrangements to determine if an asset is explicitly or implicitly specified in the agreement and if we have the right to control the use of the identified asset.

The right-of-use asset is initially measured at cost, which is primarily comprised of the initial amount of the lease liability, plus initial direct costs and lease payments at or before the lease commencement date, less any lease incentives received, and is amortized on a straight-line basis over the remaining lease term. All right-of-use assets are reviewed periodically for impairment. The lease liability is initially measured at the present value of lease payments, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the incremental borrowing rate. We elected to recognize expenses for leases with a term of 12 months or less on a straight-line basis over the lease term and not to recognize these short-term leases on the balance sheet. Leases have varying terms with remaining lease terms of up to approximately 30 years. Certain of our lease arrangements provide us with the option to extend or to terminate the lease early.

Lease payments included in the measurement of the lease liability comprise (a) fixed payments, including in-substance fixed payments; (b) variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date; (c) amounts expected to be payable under a residual value guarantee; and (d) the exercise price under a purchase option that the Company is reasonably certain to exercise, lease payments in an optional renewal period if the Company is reasonably certain to exercise an extension option, and penalties for early termination of a lease unless the Company is reasonably certain not to terminate early.

At inception or reassessment of a contract that contains lease and non-lease components, the Company allocates the consideration in the contract to each lease component on the basis of their relative stand-alone prices.

Balance Sheet location

A summary of lease right-of-use assets and liabilities are as follows:

Assets:
Property, plant and equipment
Operating lease	$	74,124
Finance lease		27,498
	$	101,622
Liabilities:
Current:
Operating lease	$	29,894
Finance lease		23,727
Non-current:
Operating lease		61,222
Finance lease		4,180
	$	119,023

Lease Expense

The components of total lease expense are as follows:

Page 27

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

	September 30, 2019
	Three months ended		Six months ended
Operating lease expense	$	2,885	$	4,867
Finance lease expense:
Amortization of right-of-use assets		374		748
Interest on lease liabilities		314		688
	$	3,573	$	6,303

Lease maturities

As of September 30, 2019, the minimum payments due for lease liabilities for each of the five succeeding fiscal years and thereafter are as follows:

	September 30, 2019
	Operating Leases			Finance Leases
2021	$	13,647		$	24,352
2022		13,124			310
2023		12,543			310
2024		11,712			321
2025		9,787			325
Thereafter		37,800			4,916
Total lease payments		98,613			30,534
Less: Interest		(7,497	)		(2,627	)
Total lease liabilities	$	91,116		$	27,907

As of September 30, 2019, we have additional operating leases that have not yet commenced with immaterial aggregated minimum payments on an undiscounted basis.

As of September 30, 2019, future lease expense for operating leases is expected to be as follows:

	September 30, 2019
2021	$	13,059
2022		12,018
2023		10,991
2024		9,821
2025		7,854
Thereafter		20,381
	$	74,124

Page 28

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

Supplemental information

Cash paid for amounts included in the measurement of lease liabilities:

	September 30, 2019
	Three months ended		Six months ended
Operating cash flows from operating leases	$	2,885	$	4,867
Operating cash flows from finance leases		374		748
Financing cash flows from finance leases		377		754
Right-of- use assets obtained in exchange for new lease liabilities:
Operating leases			$	13,370
Finance leases				—
Weighted average remaining lease term (in years):
Operating leases				7
Finance leases				3
Weighted average discount rate:
Operating leases				4.50	%
Finance leases				4.50	%

28. SEGMENTED INFORMATION

(a) Reportable segments

The Company operates in two segments. 1) Cannabis operations, which encompasses the production, distribution and sale of both medical and recreational cannabis and 2) Canopy Rivers, through which the Company provides growth capital and strategic support in the global cannabis sector, where federally lawful. Financial information for Canopy Rivers is included in the table below, and in Note 20.

	September 30, 2019			March 31, 2019
Ownership interest		28	%		28	%
Cash and cash equivalents	$	82,779		$	104,145
Prepaid expenses and other current assets		5,399			15,490
Investments in associates		66,052			64,606
Other financial assets		167,505			181,572
Other long-term assets		20,108			17,696
Deferred tax liability		(2,303	)		(6,641	)
Other liabilities		(2,807	)		(3,458	)
Non-controlling interests		(255,137	)		(280,012	)
Equity attributable to Canopy Growth	$	81,596		$	93,398

(b) Entity-wide disclosures

All property, plant and equipment and intangible assets are located in Canada, except for $488,916 which is located outside of Canada at September 30, 2019 (March 31, 2019 – $350,125).

All revenues were generated in Canada during the three and six months ended September 30, 2019, except for $34,866 and $57,407 respectively, related to medical cannabis and cannabis related devices and merchandise generated outside of Canada (three and six months ended September 30, 2018 – $2,235 and $5,610, respectively).

Page 29

CANOPY GROWTH CORPORATION

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

(Expressed in CDN $000’s except share amounts)

For the three months ended September 30, 2019, no customer represented more than 10% of the Company’s revenue (three months ended September 30, 2018 – none).

For the six months ended September 30, 2019, one customer represented more than 10% of the Company’s revenue (six months ended September 30, 2018 – none).

29. SUBSEQUENT EVENTS

These financial statements should be read in conjunction with the audited consolidated financial statements in the Company’s annual report on Form 10-K for the year ended March 31, 2020, which contain disclosures relating to subsequent events through June 1, 2020.

On June 25, 2020 the Company announced that it had entered into a proposal agreement (the “Proposal Agreement”) with Acreage to amend the terms of the arrangement (the “Existing Arrangement”) made pursuant to an arrangement agreement between the Company and Acreage dated April 18, 2019, as amended on May 15, 2019 (the “Arrangement Agreement”). Pursuant to the terms of the Proposal Agreement, the Existing Arrangement will be amended (the “Amended Arrangement”) to provide for, among other things, the following:

• The creation of two new classes of shares in the capital of Acreage with each existing Acreage subordinated voting share (each, an “Existing Share”) being converted into 0.7 of a Fixed Share (as defined below) and 0.3 of a Floating Share (as defined below), with proportionate adjustments for the existing proportionate voting shares and existing multiple voting shares;

• The new subordinated voting shares (the “Fixed Shares”) will have the same attributes as the Existing Shares and will continue to be listed on the Canadian Securities Exchange (the “CSE”). The Fixed Shares will be subject to the terms of the existing call option in favour of Canopy Growth at an amended exchange ratio equal to 0.3048 of a common share of Canopy Growth to be received for each Fixed Share held (reduced from 0.5818 per Existing Share pursuant to the Existing Arrangement);

• The new floating shares (the “Floating Shares”), which Acreage will apply to have listed on the CSE, will be subject to the terms of a new call right in favour of Canopy Growth, exercisable following the occurrence or waiver of the Triggering Event at a price equal to the 30-day volume weighted average trading price of the Floating Shares on the CSE, subject to a minimum call price of US$6.41 per Floating Share, payable in either cash or Canopy Growth common shares at Canopy Growth’s option;

• Upon implementation of the Amended Arrangement, a cash payment to Acreage shareholders and certain convertible security holders in the aggregate amount of US$37,500; and

• An aggregate of up to 32,700,000 Fixed Shares and Floating Shares that Acreage is permitted to issue following the implementation of the Amended Arrangement.

Following the occurrence or waiver (at the discretion of the Company) of the Triggering Event and subject to the satisfaction or waiver of the conditions set out in the Arrangement Agreement (as modified in connection with the Amended Arrangement), Canopy Growth will acquire all of the issued and outstanding Fixed Shares. At the time of the occurrence or waiver of the Triggering Event, Canopy Growth will also have the right, but not the obligation, to acquire all of the issued and outstanding Floating Shares. If the occurrence or waiver of the Triggering Event does not occur within 10 years from the date the Amended Arrangement is implemented, Canopy Growth’s rights to acquire both the Fixed Shares and the Floating Shares will terminate.

In connection with the Amended Agreement, Canopy Growth has agreed to loan a wholly-owned subsidiary of Acreage (“Acreage Hempco”) up to US$100,000 pursuant to a secured debenture, of which US$50,000 will be advanced upon the implementation of the Amended Arrangement, and the remaining US$50,000 will be subject to the satisfaction of certain conditions by Acreage Hempco. The secured debenture will bear interest at a rate of 6.1% per annum, and mature 10 years from the date the Amended Arrangement is implemented or such earlier date in accordance with the terms of the secured debenture.

Implementation of the Amended Arrangement is contingent upon obtaining the requisite prior approvals of the Acreage Shareholders, the Supreme Court of British Columbia and the CSE, and certain other closing conditions.

Page 30